Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB
Mandate

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

March 11, 2026 M&A Employment and Benefits Intellectual Property Commercial Agreements IT, Telecommunications and Outsourcing Data protection and processing of personal data FDI

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.

Founded in 2005 and headquartered in Gothenburg, Good Solutions serves more than 280 factories in sectors such as food and beverage, pharmaceuticals, and automotive.

Vinge’s team consisted of Filip Öhrner, Kim Bergman Aldevinge, Lovisa Jonassen, and Robert Sande (M&A), Johanna Fjellström and Linn Aho (Employment), Ian Jonson and Filippa Eriksson (IP), Nicklas Thorgerzon and Therese Baltzarsson (Commercial Agreements, IT, and GDPR), David Olander (FDI), and Filippa Bergkvist (Transaction Support Coordinator).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026